全文获取类型
收费全文 | 5912篇 |
免费 | 580篇 |
国内免费 | 318篇 |
出版年
2024年 | 13篇 |
2023年 | 125篇 |
2022年 | 222篇 |
2021年 | 314篇 |
2020年 | 269篇 |
2019年 | 296篇 |
2018年 | 244篇 |
2017年 | 162篇 |
2016年 | 197篇 |
2015年 | 263篇 |
2014年 | 446篇 |
2013年 | 548篇 |
2012年 | 341篇 |
2011年 | 356篇 |
2010年 | 274篇 |
2009年 | 253篇 |
2008年 | 274篇 |
2007年 | 345篇 |
2006年 | 264篇 |
2005年 | 258篇 |
2004年 | 203篇 |
2003年 | 185篇 |
2002年 | 126篇 |
2001年 | 77篇 |
2000年 | 91篇 |
1999年 | 103篇 |
1998年 | 86篇 |
1997年 | 38篇 |
1996年 | 58篇 |
1995年 | 24篇 |
1994年 | 58篇 |
1993年 | 42篇 |
1992年 | 37篇 |
1991年 | 42篇 |
1990年 | 22篇 |
1989年 | 28篇 |
1988年 | 18篇 |
1987年 | 21篇 |
1986年 | 11篇 |
1985年 | 19篇 |
1984年 | 18篇 |
1983年 | 10篇 |
1982年 | 6篇 |
1981年 | 3篇 |
1980年 | 4篇 |
1979年 | 6篇 |
1978年 | 3篇 |
1977年 | 2篇 |
1975年 | 3篇 |
1969年 | 1篇 |
排序方式: 共有6810条查询结果,搜索用时 15 毫秒
111.
Acute coronary syndrome (ACS) results from inadequate supply of blood flow from the coronary arteries to the heart or ischemia. ACS has an extremely high morbidity and mortality. The levels of biomarkers currently used for detection of ACS also increase in response to myocardial necrosis and other diseases and are not elevated immediately after symptoms appear, thus limiting their diagnostic capacity. Therefore, we aimed to discover new ACS diagnostic biomarkers with high sensitivity and specificity that are specifically related to ACS pathogenesis. Sera from 50 patients with ACS and healthy controls (discovery cohort) each were analyzed using mass spectrometry (MS) to identify differentially expressed proteins, and protein candidates were evaluated as ACS biomarkers in 120 people in each group (validation cohort). α-1-acid glycoprotein 1 (AGP1), complement C5 (C5), leucine-rich α-2-glycoprotein (LRG), and vitronectin (VN) were identified as biomarkers whose levels increase and gelsolin (GSN) as a biomarker whose levels decrease in patients with ACS. We concluded that these biomarkers are associated with the pathogenesis of ACS and can predict the onset of ACS prior to the appearance of necrotic biomarkers. 相似文献
112.
BackgroundMetabolic syndrome (MS) in lactating dams leads to several cardiometabolic changes related to selenium (Se) status and selenoproteins expression which produce hypertension. However, little is known about the state of these dams’ kidney functions and their Se deposits.MethodsTwo experimental groups of dam rats were used: control (Se: 0.1 ppm) and MS (Fructose 65 % and Se: 0.1 ppm). At the end of lactation (21d postpartum) kidney weight and protein content, Se deposits, and the activity of the antioxidant selenoprotein glutathione peroxidase (GPx) were measured in dams. Kidney functional parameters: albuminuria, creatinine clearance, serum aldosterone and uric acid levels and water and electrolyte (Na+ and K+) balance were also evaluated. Systolic blood pressure (SBP) was measured.ResultsIn MS dams at the end of lactation Se deposits and GPx activity are higher in the kidney; however, lipid renal peroxidation appears, relative Se clearance increases, and the dams have lost Se by urine. MS dams have polyuria and polydipsia, high uric acid serum levels, albuminuria and high creatinine clearance, implying glomerular renal malfunction with protein loss. They also present hypernatremia, hypokalemia and hyperaldosteronemia, leading to high SBP; however, a natriuretic process is taking place.ConclusionSince these alterations appear, at least in part, to be related to oxidative stress in renal cells, Se supplementation could be beneficial to avoiding greater lipid renal oxidation during lactation. 相似文献
113.
114.
Ilse Van Gucht Josephina A.N. Meester Jotte Rodrigues Bento Maaike Bastiaansen Jarl Bastianen Ilse Luyckx Lotte Van Den Heuvel Cédric H.G. Neutel Pieter-Jan Guns Mandy Vermont Erik Fransen Melanie H.A.M. Perik Joe Davis Velchev Maaike Alaerts Dorien Schepers Silke Peeters Isabel Pintelon Abdulrahman Almesned Aline Verstraeten 《American journal of human genetics》2021,108(6):1115-1125
115.
Astrid Buchberger Lena Schepergerdes Maren Flaßhoff Conrad Kunick Reinhard W. Kster 《The Journal of biological chemistry》2021,297(1)
The highly conserved dual-specificity tyrosine phosphorylation–regulated kinase 1A (Dyrk1A) plays crucial roles during central nervous system development and homeostasis. Furthermore, its hyperactivity is considered responsible for some neurological defects in individuals with Down syndrome. We set out to establish a zebrafish model expressing human Dyrk1A that could be further used to characterize the interaction between Dyrk1A and neurological phenotypes. First, we revealed the prominent expression of dyrk1a homologs in cerebellar neurons in the zebrafish larval and adult brains. Overexpression of human dyrk1a in postmitotic cerebellar Purkinje neurons resulted in a structural misorganization of the Purkinje cells in cerebellar hemispheres and a compaction of this cell population. This impaired Purkinje cell organization was progressive, leading to an age-dependent dispersal of Purkinje neurons throughout the cerebellar molecular layer with larval swim deficits resulting in miscoordination of swimming and reduced exploratory behavior in aged adults. We also found that the structural misorganization of the larval Purkinje cell layer could be rescued by pharmacological treatment with Dyrk1A inhibitors. We further reveal the in vivo efficiency of a novel selective Dyrk1A inhibitor, KuFal194. These findings demonstrate that the zebrafish is a well-suited vertebrate organism to genetically model severe neurological diseases with single cell type specificity. Such models can be used to relate molecular malfunction to cellular deficits, impaired tissue formation, and organismal behavior and can also be used for pharmacological compound testing and validation. 相似文献
116.
117.
摘要 目的:探讨六味地黄丸联合小剂量雌孕激素替代疗法对围绝经期综合征(PMS)患者性激素、骨密度和血脂的影响。方法:研究对象选取2018年12月~2020年5月期间我院接收的PMS患者93例,根据乱数表法将患者随机分为对照组(n=46)和研究组(n=47),对照组给予小剂量雌孕激素替代疗法,研究组给予六味地黄丸联合小剂量雌孕激素替代疗法,28d为一个治疗周期,对比两组患者治疗3个周期后的疗效、性激素、腰椎L2~L4骨密度、血脂、子宫内膜厚度及不良反应。结果:治疗3个周期后,研究组的总有效率为91.49%(43/47),高于对照组的76.09%(35/46)(P<0.05)。治疗3个周期后,研究组改良Kupperman评分表(KMI)、总胆固醇(TC)、甘油三酯(TG)、低密度脂蛋白胆固醇(LDL-C)、促卵泡刺激素(FSH)、促黄体生成素(LH)低于对照组,高密度脂蛋白胆固醇(HDL-C)、子宫内膜厚度、腰椎L2~L4骨密度、雌二醇(E2)高于对照组(P<0.05)。两组不良反应总发生率对比差异无统计学意义(P>0.05)。结论:六味地黄丸联合小剂量雌孕激素替代疗法治疗PMS患者,可有效缓解临床症状,提高骨密度,改善PMS患者的性激素及血脂水平,疗效确切。 相似文献
118.
摘要 目的:探讨高频振荡通气(HFOV)联合肺表面活性物质(PS)对治疗新生儿急性肺损伤/急性呼吸窘迫综合征(ALI/ARDS)的疗效及对肺动态顺应性的影响。方法:选择2018年1月至2020年12月我院新生儿科收治的160例ALI/ARDS患儿进行研究,按照随机数表法分为观察组和对照组,每组80例。对照组患儿给予常频通气(CMV)模式联合PS治疗,观察组患儿给予HFOV模式联合PS治疗。比较两组患儿一般治疗情况、治疗前后肺动态顺应性、动脉血氧分压(PaO2)、动脉二氧化氮分压(PaCO2)、氧合指数(OI)、血清肿瘤坏死因子-α(TNF-α)、白细胞介素(IL)-6、IL-10的变化,以及治疗期间并发症发生情况。结果:观察组胸片恢复正常时间、机械通气时间、氧暴露时间、ICU停留时间、住院时间结果均明显短于对照组(P<0.05),两组患儿病死率相比较,无统计学意义(P>0.05);治疗后12 h、24 h、48 h时,观察组肺动态顺应性及PaO2、OI结果明显高于对照组,PaCO2明显比对照组低,差异有统计学意义(P<0.05);治疗后48 h时,观察组血清TNF-α、IL-6水平均明显低于对照组,IL-10明显比对照组高,差异有统计学意义(P<0.05);两组治疗期间,呼吸机相关性肺损伤、颅内出血、气漏、呼吸道感染的总发生率比较,无统计学意义(P>0.05)。结论:HFOV联合PS治疗新生儿ALI/ARDS疗效明显,可有效改善患儿肺动态顺应性,促进血气分析指标恢复,且可降低炎症因子的表达,值得推广应用。 相似文献
119.
Virologica Sinica - SARS-CoV-2 has become a global pandemic threatening human health and safety. It is urgent to find effective therapeutic agents and targets with the continuous emergence of novel... 相似文献
120.
Li Jiang-Fan He Lei Deng Yong-Qiang Qi Shu-Hui Chen Yue-Hong Zhang Xiao-Lu Hu Shi-Xiong Fan Rui-Wen Zhao Guang-Yu Qin Cheng-Feng 《中国病毒学》2021,36(6):1484-1491
Virologica Sinica - The sudden emergence of severe acute respiratory syndrome coronavirus (SARS-CoV) has caused global panic in 2003, and the risk of SARS-CoV outbreak still exists. However, no... 相似文献